Use of inhibitors of bruton's tyrosine kinase (btk)

Use of inhibitors of bruton's tyrosine kinase (btk)

  • CN 104,039,325 A
  • Filed: 10/19/2012
  • Published: 09/10/2014
  • Est. Priority Date: 10/19/2011
  • Status: Active Application
First Claim
Patent Images

1. one kind for there being the individuality needing to treat the method for hematologic malignancies, it comprises to described individuality uses anticancer therapy, and wherein said individuality is accredited as the mobilization after using irreversible Btk inhibitor to described individuality with the multiple cells from this malignant tumor of increase.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×